Clinical utility of metrics based on tumor measurements in phase II trials to predict overall survival outcomes in phase III trials by using resampling methods

Ming Wen An, Yu Han, Jeffrey P. Meyers, Jan Bogaerts, Daniel J. Sargent, Sumithra J. Mandrekar

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical utility of metrics based on tumor measurements in phase II trials to predict overall survival outcomes in phase III trials by using resampling methods'. Together they form a unique fingerprint.

Medicine & Life Sciences